APA (7th ed.) Citation

Deng, Y., Shi, S., Feng, S., Tan, X., Wang, Y., Yin, J., . . . Gao, Y. (2025, August). Safety of infliximab and adalimumab in pediatric inflammatory bowel diseases: A disproportionality analysis from the FAERS database. BMC Gastroenterology.

Chicago Style (17th ed.) Citation

Deng, Yanhong, Shengying Shi, Senling Feng, Xiangping Tan, Yinling Wang, Jinjin Yin, Shaozhi Liu, and Yuanmei Gao. "Safety of Infliximab and Adalimumab in Pediatric Inflammatory Bowel Diseases: A Disproportionality Analysis from the FAERS Database." BMC Gastroenterology Aug. 2025.

MLA (9th ed.) Citation

Deng, Yanhong, et al. "Safety of Infliximab and Adalimumab in Pediatric Inflammatory Bowel Diseases: A Disproportionality Analysis from the FAERS Database." BMC Gastroenterology, Aug. 2025.